相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
G. Jones et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
J. L. Nam et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Rapid and Sustained Improvement in Bone and Cartilage Turnover Markers With the Anti-Interleukin-6 Receptor Inhibitor Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate Results From a Substudy of the Multicenter Double-Blind, Placebo-Controlled Trial of Tocilizumab in Inadequate Responders to Methotrexate Alone
Patrick Garnero et al.
ARTHRITIS AND RHEUMATISM (2010)
Tocilizumab in Systemic Lupus Erythematosus Data on Safety, Preliminary Efficacy, and Impact on Circulating Plasma Cells From an Open-Label Phase I Dosage-Escalation Study
Gabor G. Illei et al.
ARTHRITIS AND RHEUMATISM (2010)
Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis
Daichi Inoue et al.
CLINICAL RHEUMATOLOGY (2010)
Tocilizumab Ameliorates Clinical Symptoms in Polymyalgia Rheumatica
Keisuke Hagihara et al.
JOURNAL OF RHEUMATOLOGY (2010)
Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab
Toshio Tanaka et al.
RHEUMATOLOGY (2010)
Recommendations of the German Rheumatology Society on the use of tocilizumab in rheumatoid arthritis
A. Gause et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2010)
Tocilizumab for multirefractory adult-onset Still's disease
M. De Bandt et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study
N. Nishimoto et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment
S. Nishida et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Successful Treatment of Reactive Arthritis With a Humanized Anti-Interleukin-6 Receptor Antibody, Tocilizumab
Toshio Tanaka et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab
Kazuko Matsumoto et al.
CLINICAL RHEUMATOLOGY (2009)
Anti-interleukin 6: first line in rheumatoid arthritis?
Luciana Marti et al.
CLINICAL RHEUMATOLOGY (2009)
Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis
Hiroe Sato et al.
CLINICAL RHEUMATOLOGY (2009)
Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the 'age of remission'?
Robert J. Moots et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
FRESH FROM THE PIPELINE Tocilizumab
Clemens Scheinecker et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis
M. Kawai et al.
RHEUMATOLOGY (2009)
When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step?
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
P. Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study
Mark C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2008)
Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody
Norihiro Nishimoto et al.
ARTHRITIS AND RHEUMATISM (2008)
Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
Norihiro Nishimoto et al.
BLOOD (2008)
The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis
Yoshiyuki Ohsugi et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Josef S. Smolen et al.
LANCET (2008)
Mycobacterial disease in patients with rheumatic disease
Jakko van Ingen et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)
New therapies for treatment of rheumatoid arthritis
Josef S. Smolen et al.
LANCET (2007)
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): Evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
Norihiro Nishimoto et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis
Yasuaki Okuda et al.
ARTHRITIS AND RHEUMATISM (2006)
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate
R. N. Maini et al.
ARTHRITIS AND RHEUMATISM (2006)
Essential role of STAT3 in cytokine-driven NF-κB-mediated serum amyloid A gene expression
K Hagihara et al.
GENES TO CELLS (2005)
A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease
H Ito et al.
GASTROENTEROLOGY (2004)
IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system
K Hagihara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody - A multicenter, double-blind, placebo-controlled trial
N Nishimoto et al.
ARTHRITIS AND RHEUMATISM (2004)
Humanized monoclonal anti-interieukin-6 receptor antibody for treatment of intractable adult-onset Still's disease
M Iwamoto et al.
ARTHRITIS AND RHEUMATISM (2002)
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis - A randomized, double-blind, placebo-controlled, dose-escalation trial
EHS Choy et al.
ARTHRITIS AND RHEUMATISM (2002)
分享论文
